Galenica Ag Stock Performance

GALNF Stock  USD 116.19  0.00  0.00%   
Galenica has a performance score of 10 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.0749, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Galenica's returns are expected to increase less than the market. However, during the bear market, the loss of holding Galenica is expected to be smaller as well. Galenica AG right now retains a risk of 1.35%. Please check out Galenica standard deviation, maximum drawdown, as well as the relationship between the Maximum Drawdown and day median price , to decide if Galenica will be following its current trending patterns.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Galenica AG are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Galenica may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more
Begin Period Cash Flow59.8 M
Total Cashflows From Investing Activities-88.2 M
  

Galenica Relative Risk vs. Return Landscape

If you would invest  10,500  in Galenica AG on November 13, 2025 and sell it today you would earn a total of  1,119  from holding Galenica AG or generate 10.66% return on investment over 90 days. Galenica AG is currently producing 0.1719% returns and takes up 1.3535% volatility of returns over 90 trading days. Put another way, 12% of traded pink sheets are less volatile than Galenica, and 97% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Galenica is expected to generate 1.74 times more return on investment than the market. However, the company is 1.74 times more volatile than its market benchmark. It trades about 0.13 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.

Galenica Target Price Odds to finish over Current Price

The tendency of Galenica Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 116.19 90 days 116.19 
about 23.55
Based on a normal probability distribution, the odds of Galenica to move above the current price in 90 days from now is about 23.55 (This Galenica AG probability density function shows the probability of Galenica Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Galenica has a beta of 0.0749. This usually indicates as returns on the market go up, Galenica average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Galenica AG will be expected to be much smaller as well. Additionally Galenica AG has an alpha of 0.7443, implying that it can generate a 0.74 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Galenica Price Density   
       Price  

Predictive Modules for Galenica

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Galenica AG. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
114.84116.19117.54
Details
Intrinsic
Valuation
LowRealHigh
104.57133.80135.15
Details

Galenica Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Galenica is not an exception. The market had few large corrections towards the Galenica's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Galenica AG, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Galenica within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.74
β
Beta against Dow Jones0.07
σ
Overall volatility
8.31
Ir
Information ratio 0.13

Galenica Fundamentals Growth

Galenica Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Galenica, and Galenica fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Galenica Pink Sheet performance.

About Galenica Performance

By analyzing Galenica's fundamental ratios, stakeholders can gain valuable insights into Galenica's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Galenica has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Galenica has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Galenica AG operates as a healthcare service provider in Switzerland and internationally. The company was founded in 1927 and is headquartered in Bern, Switzerland. Galenica operates under Medical Distribution classification in the United States and is traded on OTC Exchange. It employs 5517 people.

Things to note about Galenica AG performance evaluation

Checking the ongoing alerts about Galenica for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Galenica AG help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Evaluating Galenica's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Galenica's pink sheet performance include:
  • Analyzing Galenica's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Galenica's stock is overvalued or undervalued compared to its peers.
  • Examining Galenica's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Galenica's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Galenica's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Galenica's pink sheet. These opinions can provide insight into Galenica's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Galenica's pink sheet performance is not an exact science, and many factors can impact Galenica's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Galenica Pink Sheet analysis

When running Galenica's price analysis, check to measure Galenica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galenica is operating at the current time. Most of Galenica's value examination focuses on studying past and present price action to predict the probability of Galenica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galenica's price. Additionally, you may evaluate how the addition of Galenica to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Global Correlations
Find global opportunities by holding instruments from different markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios